PHILIP DINEEN: Open Payments
NPI 1972974988 · MORGANTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 14 payments from 8 companies in 2025. Trend: 2023 $937 · 2024 $584 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Amgen Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Wegovy, Kerendia, LEQVIO, ELIQUIS, CAMZYOS, WAINUA, REPATHA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
